Inflammaging as a prodrome to Alzheimer's disease
2008

Inflammaging and Alzheimer's Disease

publication 10 minutes Evidence: moderate

Author Information

Author(s): Brian Giunta, Francisco Fernandez, William V. Nikolic, Demian Obregon, Elona Rrapo, Terrence Town, Jun Tan

Primary Institution: University of South Florida, College of Medicine

Hypothesis

Does inflammaging perpetrate and/or exacerbate Alzheimer's disease?

Conclusion

Inflammaging may serve as a prodrome or an exacerbating factor for the development of Alzheimer's disease.

Supporting Evidence

  • Inflammaging is characterized by a chronic low-grade inflammatory state.
  • Pro-inflammatory cytokines are associated with the pathology of Alzheimer's disease.
  • Certain treatments can mitigate the effects of inflammaging in mouse models.

Takeaway

As people get older, their immune system can become overly active, which might lead to diseases like Alzheimer's. Finding ways to calm this immune response could help prevent or treat Alzheimer's.

Methodology

The review discusses the aging immune system and how certain treatments can counteract the effects of inflammaging in mouse models.

Potential Biases

Potential bias in interpreting results from animal studies when applied to human conditions.

Limitations

The findings are primarily based on animal models, and human studies are needed to confirm the results.

Statistical Information

P-Value

p = 0.02

Confidence Interval

95% CI 0.6–5.4

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1742-2094-5-51

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication